{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:21:04Z","timestamp":1790767264276,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology, Executive Yuan, Taiwan"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.bpg.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T11:16:58Z","timestamp":1442056618000},"page":"907-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Hepatitis B vaccination and prevention of hepatocellular carcinoma"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2015.09.011_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bpg.2015.09.011_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection","volume":"2","author":"Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpg.2015.09.011_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib4","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"Gomaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2015.09.011_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-380888-2.00002-9","article-title":"Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects","volume":"108","author":"Kao","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.bpg.2015.09.011_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/he.2000.6709","article-title":"Clinical relevance of hepatitis B viral mutations","volume":"31","author":"Hunt","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021436","article-title":"Hepatitis B virus genotypes and variants","volume":"5","author":"Lin","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvh.12370","article-title":"Treating immune-tolerant hepatitis B","volume":"22","author":"Tseng","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.bpg.2015.09.011_bib9","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s10620-010-1179-4","article-title":"Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection","volume":"55","author":"Liaw","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2015.09.011_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/infdis\/jir687","article-title":"Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters","volume":"205","author":"Tseng","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bpg.2015.09.011_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2015.09.011_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2015.09.011_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1440-1746.2011.06695.x","article-title":"Natural history of chronic hepatitis B REVEALed","volume":"26","author":"Chen","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2015.09.011_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2011.04.046","article-title":"Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters","volume":"141","author":"Tseng","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2015.09.011_bib16","article-title":"Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers","author":"Tseng","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2015.09.011_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.24615","article-title":"Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load","volume":"55","author":"Tseng","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jgh.12010","article-title":"Risk stratification for hepatitis B virus related hepatocellular carcinoma","volume":"28","author":"Lin","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib19","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1517\/14656566.2011.590474","article-title":"Recent advances in the treatment of chronic hepatitis B","volume":"12","author":"Lin","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bpg.2015.09.011_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/17474124.2015.960398","article-title":"Improving clinical outcomes of chronic hepatitis B virus infection","volume":"9","author":"Su","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jfma.2013.02.001","article-title":"Hepatitis B viral factors and treatment responses in chronic hepatitis B","volume":"112","author":"Lin","year":"2013","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.bpg.2015.09.011_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib23","first-page":"1284A","article-title":"The C-TEAM study group. Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy \u2013 a follow-up report of C-TEAM study","volume":"60","author":"Su","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2015.09.011_bib25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrgastro.2015.8","article-title":"HBV cure-can we pin our hopes on immunotherapy?","volume":"12","author":"Yang","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib27","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"WHO","year":"2015"},{"issue":"Suppl.","key":"10.1016\/j.bpg.2015.09.011_bib28","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1046\/j.1440-1746.2000.02095.x","article-title":"Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region","volume":"15","author":"Chen","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib29","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1056\/NEJMcp041507","article-title":"Clinical practice: prevention of hepatitis B with the hepatitis B vaccine","volume":"351","author":"Poland","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021493","article-title":"Prevention of hepatitis B","volume":"5","author":"Chang","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib31","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bpg.2015.09.011_bib32","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bpg.2015.09.011_bib33","series-title":"Recommendations for routine testing and follow-up for chronic hepatitis B virus (HBV) infection. Adapted from CDC\/Travellers' Health; Yellow Book","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1016\/j.bpg.2015.09.011_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjmed.2008.09.002","article-title":"Universal hepatitis B vaccination: killing 2 birds with 1 stone","volume":"121","author":"Kao","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(05)67544-7","article-title":"Hepatitis B vaccination: to boost or not to boost?","volume":"366","author":"Kao","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2015.09.011_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of hepatitis B infection by a 25-year universal vaccination program","volume":"57","author":"Ni","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","article-title":"Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies","volume":"132","author":"Ni","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2015.09.011_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.03.013","article-title":"Slow decline of hepatitis B burden in general population: results from a population-based survey and longitudinal follow-up study in Taiwan","author":"Chen","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib39","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.bpg.2015.09.011_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3904\/kjim.2013.28.4.413","article-title":"Recent trends in hepatitis B virus infection in the general Korean population","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986\u201390) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bpg.2015.09.011_bib42","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2015.09.011_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001774","article-title":"Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial","volume":"11","author":"Qu","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.bpg.2015.09.011_bib46","first-page":"507","article-title":"Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program","volume":"9","author":"Wichajarn","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.bpg.2015.09.011_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.24500","article-title":"Fighting against viral hepatitis: lessons from Taiwan","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","article-title":"Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention","volume":"59","author":"Wen","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.09.011_bib50","article-title":"Taiwan Study Group for the prevention of mother-to-infant transmission of HBV (PreMIT study). Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2015.09.011_bib51","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/emi.2014.64","article-title":"Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance","volume":"3","author":"Yang","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bpg.2015.09.011_bib52","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in\u00a0vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bpg.2015.09.011_bib53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fvl.14.36","article-title":"Strategies to eliminate HBV infection","volume":"9","author":"Kapoor","year":"2014","journal-title":"Future Virol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:22:04Z","timestamp":1537348924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691815001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1521691815001249"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2015.09.011","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B vaccination and prevention of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}